- Operationally derisks us by reducing the dependency upon the board members to 'run the bank'
- Potentially adds a lot of extra horse power to organic growth
- Presumably will accelerate future acquisition integrations
Whilst the regulatory approval will take until Q3 I wouldn't be surprised if the teams have already been working closely together for some time now. 'I liked the product so much I bought the company'
Now we just need the next acquisition or two to be for large slices of AUM and we'll really be at the races.
It was certainly asked a while ago and an update around the strategy for the fund was going to be forthcoming along with an update about the AUM injection. We then haven't received either so definitely worth querying with IR I'd say.
Yeah I've had that debate with him a couple of times now. Broadly their view is that the broker note contains all the information we'd get in an operational update with the broker having extra scope to include forward looking estimates etc. that the company isn't allowed to issue themselves.
Don't get me wrong I like the broker notes and there's loads of really important information in them but I'd rather we had both.
Broker Notes are being used as the mains comms mechanism for shareholders and the latest one was in November so not that long ago. All are held here in case anyone hasn't seen them: https://www.allenbycapital.com/client/alpha-growth-plc/
Next two updates I'm expecting are the completion of due diligence on the latest acquisition target combined with details on the scale of the target then an update on the large inflow of funds into the Interval Fund which now seems to be up to almost $20m. https://markets.businessinsider.com/funds/alpha-alternative-assets-fund-us00216g1040
Definitely agree that patience is required here, hopefully without the tears :)
Doubt there’s any news. Just someone selling into the recent rises and I notice the late printed 467K buy. I suspect the shares sold today will have already found a new home.